-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Nutrien, Lowers Price Target to $78

Benzinga·08/11/2026 13:57:38
Listen to the news
Barclays analyst Benjamin Theurer maintains Nutrien (NYSE:NTR) with a Overweight and lowers the price target from $81 to $78.